Oncothyreon

- oncothyreon.com

Oncothyreon is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients.

4,256,068 $ 240.00

Andarix Pharmaceuticals, Inc.

- andarix.info

Andarix Pharmaceuticals is a clinical stage company developing a targeted personalized treatment for lung, breast and other cancers based on a proprietary somatostatin peptide conjugate (P2045). Extensive research has demonstrated that Somatostatin receptors are highly up-regulated on several solid tumors, particularly

Not Applicable $ 8.95

Cure for Cancers - Information regarding natural ways to cure cancers

- cureforcancers.net

Free information on cure for cancers, natural way to recover without taking drugs or doing surgery

Not Applicable $ 8.95

IRESSA® (gefitinib) | Information and resources

- medicationforlungcancer.com

Learn about IRESSA (gefitinib), now approved for first-line treatment of EGFR mutation–positive patients with metastatic NSCLC

Not Applicable $ 8.95

First-line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer

- treatmentoptionformetassqnsclc.com

Portrazza in combination with gemcitabine and cisplatin, is the first approved biologic for the treatment of patients who are chemo-naive for their metastatic non-small cell lung cancer.

Not Applicable $ 8.95

OPDIVO® (nivolumab) | Patient Gateway

- opdivo.site

OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.

Not Applicable $ 8.95